A Pilot Study of MONOtherapy of DOlutegravir in HIV-1 Virologically Suppressed Patients

Clinical trial NCT02572947 · COMPLETED

Trial details

NCT number: NCT02572947
Sponsor: Calmy Alexandra
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Human Immunodeficiency Virus Dolutegravir Monotherapy Treatment Efficacy

Start date: 2016-06-01
Primary completion: 2017-06-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.